Brief: ProAssurance Q2 Net Income USD 21.921 Million

ProAssurance

05/08/2025 21:15

Overview

ProAssurance Q2 net income beats analyst expectations, per LSEG data

Adjusted operating income for Q2 exceeds estimates, per LSEG data

Co's merger with The Doctors Company approved by stockholders, FTC grants early termination

Outlook

Company anticipates merger with The Doctors Company to close in H1 2026

ProAssurance focuses on disciplined underwriting and cost management

Result Drivers

STABLE PREMIUMS - Medical Professional Liability segment maintained stable net premiums, offset by declines in other lines

RATE INCREASES - Specialty P&C renewal premiums increased by 10%, contributing to a cumulative premium change of over 70% since 2018

RESERVE DEVELOPMENT - Improved combined ratios largely due to favorable prior year reserve development

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Gross Premiums
$216.93 mln
Q2 Net Income
Beat
$21.92 mln
$10.20 mln (3 Analysts)
Q2 Adjusted Operating Income
Beat
$26.77 mln
$8.09 mln (1 Analyst)
Q2 Pretax Profit
Beat
$27.44 mln
$10.30 mln (1 Analyst)

Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 5 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the property & casualty insurance peer group is "buy."

Wall Street's median 12-month price target for ProAssurance Corp is $25.00, about 4.8% above its August 4 closing price of $23.80

The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 24 three months ago

Press Release: ID:nBwbwFnRha

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)